CNTX logo

Context Therapeutics (CNTX) Depreciation And Amortization

Annual D&A

$12.00 K
+$2700.00+29.03%

31 December 2023

CNTX Depreciation And Amortization Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly D&A

$2800.00
+$200.00+7.69%

01 September 2024

CNTX Quarterly D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM D&A

$10.60 K
-$300.00-2.75%

01 September 2024

CNTX TTM D&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

CNTX Depreciation And Amortization Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+29.0%-9.7%-16.5%
3 y3 years-+100.0%+100.0%
5 y5 years---

CNTX Depreciation And Amortization High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high-12.5%-17.2%
5 y5 yearsat high-12.5%-17.2%
alltimeall timeat high-12.5%-17.2%

Context Therapeutics Depreciation And Amortization History

DateAnnualQuarterlyTTM
Sept 2024
-
$2800.00(+7.7%)
$10.60 K(-2.8%)
June 2024
-
$2600.00(0.0%)
$10.90 K(-5.2%)
Mar 2024
-
$2600.00(0.0%)
$11.50 K(-5.0%)
Dec 2023
$12.00 K(+29.0%)
$2600.00(-16.1%)
$12.10 K(-4.7%)
Sept 2023
-
$3100.00(-3.1%)
$12.70 K(-0.8%)
June 2023
-
$3200.00(0.0%)
$12.80 K(+2.4%)
Mar 2023
-
$3200.00(0.0%)
$12.50 K(+34.4%)
DateAnnualQuarterlyTTM
Dec 2022
$9300.00(>+9900.0%)
$3200.00(0.0%)
$9300.00(+52.5%)
Sept 2022
-
$3200.00(+10.3%)
$6100.00(+110.3%)
June 2022
-
$2900.00(>+9900.0%)
$2900.00(>+9900.0%)
Mar 2022
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2021
$0.00
$0.00(0.0%)
$0.00(0.0%)
Sept 2021
-
$0.00(0.0%)
$0.00(0.0%)
June 2021
-
$0.00
$0.00

FAQ

  • What is Context Therapeutics annual depreciation & amortization?
  • What is the all time high annual D&A for Context Therapeutics?
  • What is Context Therapeutics annual D&A year-on-year change?
  • What is Context Therapeutics quarterly depreciation & amortization?
  • What is the all time high quarterly D&A for Context Therapeutics?
  • What is Context Therapeutics quarterly D&A year-on-year change?
  • What is Context Therapeutics TTM depreciation & amortization?
  • What is the all time high TTM D&A for Context Therapeutics?
  • What is Context Therapeutics TTM D&A year-on-year change?

What is Context Therapeutics annual depreciation & amortization?

The current annual D&A of CNTX is $12.00 K

What is the all time high annual D&A for Context Therapeutics?

Context Therapeutics all-time high annual depreciation & amortization is $12.00 K

What is Context Therapeutics annual D&A year-on-year change?

Over the past year, CNTX annual depreciation & amortization has changed by +$2700.00 (+29.03%)

What is Context Therapeutics quarterly depreciation & amortization?

The current quarterly D&A of CNTX is $2800.00

What is the all time high quarterly D&A for Context Therapeutics?

Context Therapeutics all-time high quarterly depreciation & amortization is $3200.00

What is Context Therapeutics quarterly D&A year-on-year change?

Over the past year, CNTX quarterly depreciation & amortization has changed by -$300.00 (-9.68%)

What is Context Therapeutics TTM depreciation & amortization?

The current TTM D&A of CNTX is $10.60 K

What is the all time high TTM D&A for Context Therapeutics?

Context Therapeutics all-time high TTM depreciation & amortization is $12.80 K

What is Context Therapeutics TTM D&A year-on-year change?

Over the past year, CNTX TTM depreciation & amortization has changed by -$2100.00 (-16.54%)